Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Current Assets (2020 - 2026)

BioScience Health Innovations has reported Current Assets over the past 7 years, most recently at $2.2 million for Q1 2026.

  • Quarterly Current Assets rose 63.93% to $2.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Mar 2026, up 63.93% year-over-year, with the annual reading at $1.6 million for FY2025, 83.86% up from the prior year.
  • Current Assets was $2.2 million for Q1 2026 at BioScience Health Innovations, up from $1.6 million in the prior quarter.
  • Over five years, Current Assets peaked at $2.2 million in Q1 2026 and troughed at $16253.0 in Q3 2022.
  • The 5-year median for Current Assets is $154798.0 (2024), against an average of $653912.5.
  • Year-over-year, Current Assets surged 829.48% in 2025 and then soared 63.93% in 2026.
  • A 5-year view of Current Assets shows it stood at $28343.0 in 2022, then surged by 229.49% to $93388.0 in 2023, then soared by 807.77% to $847751.0 in 2024, then surged by 83.86% to $1.6 million in 2025, then surged by 40.82% to $2.2 million in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Current Assets are $2.2 million (Q1 2026), $1.6 million (Q4 2025), and $2.0 million (Q3 2025).